Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma

Conclusion: Differences in the intestinal microbiomes and their functions may influence the incidence of diarrhea during lenvatinib treatment.
Source: Digestive Diseases - Category: Gastroenterology Source Type: research